Neurocrine Biosciences
NBIX
#1682
Rank
ยฃ9.73 B
Marketcap
ยฃ96.98
Share price
-0.39%
Change (1 day)
4.60%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of December 2025 : ยฃ2.41 Billion

According to Neurocrine Biosciences 's latest financial reports the company has ยฃ2.41 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$ยฃ2.41 B17.05%
2024-12-31$ยฃ2.06 B17.79%
2023-12-31$ยฃ1.75 B24.11%
2022-12-31$ยฃ1.41 B38.68%
2021-12-31$ยฃ1.01 B23.2%
2020-12-31$ยฃ0.82 B70.11%
2019-12-31$ยฃ0.48 B28.24%
2018-12-31$ยฃ0.37 B37.55%
2017-12-31$ยฃ0.27 B7.9%
2016-12-31$ยฃ0.25 B-10.9%
2015-12-31$ยฃ0.28 B113.67%
2014-12-31$ยฃ0.13 B83.63%
2013-12-31$ยฃ72.99 M-23.57%
2012-12-31$ยฃ95.5 M147.08%
2011-12-31$ยฃ38.65 M208.46%
2010-12-31$ยฃ12.53 M412.86%
2009-12-31$ยฃ2.44 M-90.26%
2008-12-31$ยฃ25.09 M-58.01%
2007-12-31$ยฃ59.74 M-62.81%
2006-12-31$ยฃ0.16 B-28.98%
2005-12-31$ยฃ0.22 B10.28%
2004-12-31$ยฃ0.20 B-6.18%
2003-12-31$ยฃ0.21 B56.33%
2002-12-31$ยฃ0.13 B-34.67%
2001-12-31$ยฃ0.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
ยฃ69.11 B 2,761.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-ยฃ1.93 Billion-179.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ19.69 B 715.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ1.54 B-35.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ27.02 Million-101.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.37 B-84.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ0.29 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ7.21 B 198.64%๐Ÿ‡ฌ๐Ÿ‡ง UK